Medifast Second Quarter Revenue Falls 37.4 Percent as Active OPTAVIA Coaches Drop to 22,800

BALTIMORE, Md. -- August 4, 2025

Medifast, the parent of OPTAVIA, reported second-quarter 2025 revenue of 105.6 million dollars, down 37.4 percent from 168.6 million dollars a year earlier, as the number of active earning OPTAVIA coaches fell 32.7 percent to 22,800 from 33,900. Average revenue per active earning coach declined to 4,630 dollars from 4,972 dollars, reflecting continued difficulty acquiring clients amid the rapid adoption of GLP-1 weight-loss medications.

The company posted net income of 2.5 million dollars, or 0.22 dollars per diluted share, including a 2.0 million dollar after-tax gain on its investment in LifeMD, compared with a net loss of 8.2 million dollars, or 0.75 dollars per share, a year earlier. Medifast sold its LifeMD shares during the quarter but said its collaboration with the telehealth company continues. Selling, general and administrative expenses fell 40.8 percent, largely because of lower coach compensation.

Chief Executive Dan Chard said the company is focused on reigniting coach growth and productivity and on metabolic health. Medifast forecast third-quarter revenue of 70 million to 90 million dollars and results ranging from a loss of 0.60 dollars per share to breakeven. It ended June with 162.7 million dollars in cash and investments and no debt.